Title : Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.

Pub. Date : 2003 Jun 3

PMID : 12742991






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study therefore evaluated the hypothesis that diabetic patients have elevated plasma levels of soluble CD40L (sCD40L) and that treatment with the insulin-sensitizing thiazolidinediones lowers this index of inflammation. Thiazolidinediones CD40 ligand Homo sapiens